2019
Sarosiek S, Sanchorawala V. Treatment Options for Relapsed/Refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. J Blood Med. 2019 Oct 23; 10:373-380. View in PubMed
Elliot J, Zhou L, Chunyu C and Kaku M. A 63-Year-Old Man with Nausea, Vomiting, Orthostatic Dizziness, and Distal Limb Paresthesia. In: Zhou L, Burns D, Chunyu C. (A Case-Based Guide to Neuromuscular Pathology.) Springer, 2019. https://www.amazon.com/Case-Based-Guide-Neuromuscular-Pathology/dp/3030256812
Kaku M, Berk JL. Neuropathy Associated with Systemic Amyloidosis. Semin Neurol. 2019 Oct;39(5):578-588. doi: 10.1055/s-0039-1688994. Epub 2019 Oct 22. View in PubMed
A Angel-Korman, A Jaberi, V Sanchorawala, A Havasi. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid Journal 2019. 09 Oct 2019.
Gopal D, Ruberg FL, Siddiqi O Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. 2019 Sep 13. doi: 10.1007/s11897-019-00436-z View in PubMed
Lilleness B, Doros G, Ruberg FL, Sanchorawala V. Establishment of brain natriuretic peptide-based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. Br J Haematol. 2019 Sep 13. doi: 10.1111/bjh.16198. View in PubMed
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. SNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2 – Evidence base and Standardized methods of imaging. 2019 Aug 6. doi: 10.1016/j.cardfail.2019.08.001. View in PubMed
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM.
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. 2019 Aug 6. doi: 10.1016/j.cardfail.2019.08.002. View in PubMed
Law ST, Reza Jafarzadeh S, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of major salivary glands in Sarcoidosis, Amyloidosis, and Sjögren’s Syndrome. Arthritis Care Res, (Hoboken). 2019 Jul 15. View in PubMed
Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala, V. A new era of amyloidosis: the trends at a major US referral. Amyloid, The Journal of Protein Folding Disorders, July 2019. View online
Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S. Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis. Am J Hematol, 2019, Jul 11. doi: 10. 1002/ajh.25576 [Epub ahead of print]. View online
Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol, 2019, June 11; 73 (22): 2872-2891. View in PubMed.
McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V. Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis. British Journal of Haematology, 2019, 185, 940-1007. View online
Sanchorawala V, Doros G, Shelton, AC. Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of AL amyloidosis: A pooled analysis. Am J Hematol. 2019 April 24. doi: 10. 1022/ajh.25497. View in PubMed
Morgan GJ, Yan NL , Mortenson DE, Rennella E, Blundon JM, Gwin RM, Lin CY, Stanfield RL, Brown SJ, Rosen H, Spicer TP, Fernandez-Vega V, Merlini G, Kay LE, Wilson IA, Kelly JW. Stabilization of amyloidogenic immunoglobulin light chains by small molecules. Proceedings of National Academy of Sciences of the United States of America. 2019 Apr 10. doi: 10.1073/pnas.1817567116. View in PubMed
Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S. Early Detection of Multiorgan Light Chain (AL) Amyloidosis by Whole Body 18F-florbetapir PET/CT. Journal of Nuclear Medicine. 6 April 2019 dio:10.2967/jnumed.118.221770. View in PubMed
Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-Up Analysis. Biology of Blood and Marrow Transplantation. 11 Jan 2019. doi: 10.1016/j.bbmt.2019.01.007. View in PubMed
Lilleness B, Ruberg FL, Mussinelli R, Gheorghe D, and Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. American Society of Hematology. 17 Jan 2019, 133 (2019). doi: https://doi.org/10.1182/blood-2018-06-858951. View in PubMed
Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplantation. 21 Jan 2019. doi: 10.1038/s41409-019-0440-5. View in PubMed
Sanchorawala V. Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details.. Blood Advances. 22 Jan 2019. doi: 10.1182/bloodadvances.2018021261. View in PubMed